iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Mankind Pharma raises Rs 1298 crore from anchor book; issue opens for subscription today

25 Apr 2023 , 09:00 AM

Ahead of initial public offer (IPO), the pharmaceutical company Mankind Pharma mobilised Rs 1,297.9 crore from anchor investors. 

The company has allotted over 1.2 crore shares to 77 funds at Rs 1,080 apiece, at the end of the price band, aggregating to Rs 1,298 crore.

The investors that participated in the offer included Canada Pension Plan, Government of Singapore, Monetary Authority of Singapore, Goldman Sachs, Fiam Group Trust, Blackrock Global Funds, Abu Dhabi Investment Authority, Nomura Funds, Morgan Stanley, and Neuberger Berman Emerging Markets Equity Fund.

HDFC Trustee, SBI Mutual Fund, Fidelity Investment, Motilal Oswal Mutual Fund, Nippon Life India, Axis Mutual Fund, Kotak Mutual Fund, Aditya Birla Sun Life Trustee, Franklin India, ICICI Prudential Life Insurance, HDFC Life Insurance, SBI Life Insurance, Tata Mutual Fund, and Kotak Mahindra Life Insurance also made an investment in the company via anchor book.

As per BSE circular, “Trading Members of the Exchange are hereby informed that, under Anchor Investors (AIs) portion in the Public Issue of Mankind Pharma Limited, 1,20,17,652 equity shares have been subscribed today at Rs. 1,080/- per equity share. A copy of the Announcement dated April 24, 2023, issued by the Company in this regard is enclosed for your reference.”

The subscription of the IPO will be opening today, April 25 at 10 am and will conclude on April 27. The issue has a price band of Rs 1,026-1,080 a share. At the upper end of the price band, the IPO size is estimated at Rs 4,326 crore. Click here to subscribe the IPO,

The issue is completely an offer for sale with no component for fresh issue. Therefore, the company will not get any proceeds from the issue.

Mankind Pharma IPO important details

Open date  April 25
Close date  April 27
Lot size 13
IPO size (Rs crore) Rs 4,326.36 Cr
IPO price range (Rs) Rs 1026-1080 per share
Minimum investment Rs 14,040
Basis of allotment date May 3
Refunds date  May 4
Credit to demat account date  May 5
Listing date  May 8
Open date  April 21
Close date  April 25
Lot size 13
IPO size (Rs crore) Rs 4,326.36 Cr
IPO price range (Rs) Rs 1026-1080 per share
Minimum investment Rs 14,040
Basis of allotment date April 28
Refunds date  May 2
Credit to demat account date  May 3
Listing date  May 4

 

Mankind Pharma IPO

Related Tags

  • anchor book
  • mankind ipo
  • Mankind Pharma
  • mankind pharma important details
  • Mankind Pharma IPO
  • mankind pharma opening date
  • Mankind Pharma subscribe
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.